Sun Pharma to acquire remaining stake in subsidiary Taro for $348 million
Thursday, 18 January 2024 Sun Pharma has announced its intention to acquire the remaining shares of its Israeli subsidiary, Taro Pharma, at a rate of $43 per share, totaling approximately $348 million. This acquisition cost represents 21.52% of Taro's total outstanding shares. Sun Pharma, holding a current stake of about 78.5% in Taro, initially proposed to purchase the remaining stake at $38 per share in May. Following the anticipated conclusion of the merger, slated for the first half of 2024, Taro is set to transition into a privately held company.
As of June 2020, NASAβs Solar Dynamics Observatory β SDO β has now been watching the Sun non-stop for over a full decade. From its orbit in space around the Earth, SDO has gathered 425 million..
Thursday, 18 January 2024
![A Decade of Sun [Video]](https://video.newsserve.net/300/v/20240107/1704660514-Decade-of-Sun.jpg)
